tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences

Need an answer now?

Give us a call

01 30 46 39 00

Leave a message, we'll get back to you

Immune Checkpoint Reporter Cell based assays

In drug discovery research, combining classical Biochemical assays with cell based assays increases your understanding by obtaining more accurate and physiological results in a cellular context.

  • Complement and confirm biochemical results
  • Distinguish agonist versus antagonistic binding effect of your target compared to Biochemical assays
  • Study in a cellular context with whole cell signalling pathway
  • Increase your rate of success in identifying new drug treatment candidates

Gain more insight on these Immune Checkpoint cell based assays - download the poster "Methods for Drug Discovery Through Biochemical and Cell Based Assays for Immunotherapy Checkpoint Activators and Inhibitors" presented by BPS Bioscience at the Immuno-Oncology Summit in Boston this year (2017).

Download the poster here

Read more about it on tebu-bio's blog here:

"Drug discovery: Immunotherapy checkpoint research for new Cancer treatments"